CancerNetwork, an arm of the prestigious journal Oncology, joined LFSA at the 7th International LFS Association Symposium to report on the latest advances in LFS research and clinical therapies. Reflected here are highlights of presentations by global experts.. Among them, Payal Khincha, MBBS, MSHS, shared a presentation on the progress of using metformin to reduce the risk or delaying the onset of cancer among those with LFS.
“There’s been over a decade’s worth of groundbreaking work that has laid the foundation of why we think we have a sound biologic foundation for metformin to be something that potentially works in Li-Fraumeni syndrome.”
Hear more from Khincha, a Lasker Clinical Research Scholar in the Division of Cancer Epidemiology and Genetics at the National Cancer Institute, in this interview: Sound Biologic Foundation May Support Metformin in Li-Fraumeni Syndrome
